Can we prevent seasonal affective disorder (SAD) with melatonergic agents?

Please use this identifier to cite or link to this item: https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/764

Full metadata record

DC Field	Value	Language
dc.contributor.author	Zghoul, Tarek
dc.date.accessioned	2021-03-31T17:03:12Z
dc.date.available	2021-03-31T17:03:12Z
dc.date.issued	2020-06
dc.identifier.citation	Zghoul, T. (2020). Can we prevent seasonal affective disorder (SAD) with melatonergic agents? BJPsych Advances, 26(4), 193-197.	en
dc.identifier.uri	https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/764
dc.description	The article attached to this record is the Author(s) pre-/post- print version only. NOTE: this is not the version published in BJPsych Advances. Minor changes may have been made for publication. Eligible users can access the full text via NHS OpenAthens (login required)
dc.description.abstract	Seasonal affective disorder (SAD) is a recurrent form of major depression, particularly occurring in the winter months with a generally spontaneous remission in spring/summer. The predictable nature of this condition provides a potentially unique opportunity to prevent recurrence in sufferers of SAD. The Cochrane Review discussed here examines the evidence for melatonin and agomelatine in preventing SAD, putting its findings into their clinical context.	en
dc.description.uri	https://doi.org/10.1192/bja.2020.25	en
dc.language.iso	en	en
dc.subject	Seasonal Affective Disorder (SAD)	en
dc.title	Can we prevent seasonal affective disorder (SAD) with melatonergic agents?	en
dc.type	Preprint	en
dc.contributor.discipline	Medical Trainee	en
Appears in Collections:	Depressive Disorders BJPsych Advances publications

Files in This Item:

File	Description	Size	Format
Tarek Zghoul.docx	PrePrint	57.55 kB	Microsoft Word XML	View/Open

DSpace JSPUI